Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9943549 | 0.83 | — | — | |
| SCHEMBL20855349 | 0.73 | TDP1 (0.38) | — | |
| SCHEMBL9943400 | 0.70 | RIPK1 (0.32) | — | |
| SCHEMBL3930052 | 0.69 | — | — | |
| SCHEMBL959395 | 0.68 | TDP1 (0.31) | — | |
| SCHEMBL25170909 | 0.68 | SMN1; SMN2 (0.33) | SMN1; SMN2 | |
| SCHEMBL7177266 | 0.68 | HDAC6 (0.35) | — | |
| SCHEMBL3697035 | 0.67 | — | — | |
| SCHEMBL3903619 | 0.65 | TSHR (0.36) | — | |
| SCHEMBL22117974 | 0.64 | TDP1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11492327-B2 | Aminooxylipids for the construction of self-assembling liposomal systems enabling their subsequent modification by biologically functional molecules | VYSOKA SKOLA CHEMICKO-TECHNOLOGICKA V PRAZE (CZ) | 2022-11-08 | — | — | US | disclosed |
| US-20210292275-A1 | AMINOOXYLIPIDS FOR THE CONSTRUCTION OF SELF-ASSEMBLING LIPOSOMAL SYSTEMS ENABLING THEIR SUBSEQUENT MODIFICATION BY BIOLOGICALLY FUNCTIONAL MOLECULES | VYSOKA SKOLA CHEMICKO-TECHNOLOGICKA V PRAZE (CZ) | 2021-09-23 | — | — | US | disclosed |
| EP-3535238-B1 | AMINOOXYLIPIDS FOR THE CONSTRUCTION OF SELF-ASSEMBLING LIPOSOMAL SYSTEMS ENABLING THEIR SUBSEQUENT MODIFICATION BY BIOLOGICALLY FUNCTIONAL MOLECULES | VS CHEMICKO TECHNOLOGICKA V PRAZE (CZ) | 2021-04-21 | — | — | EP | disclosed |
| US-5272253-A | Cluster conjugates of drugs with antibodies | ELI LILLY AND COMPANY (US) | 1993-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11492327-B2 | Aminooxylipids for the construction of self-assembling liposomal systems enabling their subsequent modification by biologically functional molecules | LIPC, LYPLA2, PNLIP | SMN1; SMN2 3503/4885 |
| US-20210292275-A1 | AMINOOXYLIPIDS FOR THE CONSTRUCTION OF SELF-ASSEMBLING LIPOSOMAL SYSTEMS ENABLING THEIR SUBSEQUENT MODIFICATION BY BIOLOGICALLY FUNCTIONAL MOLECULES | LIPC, LYPLA2, PNLIP | SMN1; SMN2 3503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.